UNSPSC 51161532: Binizolast

This classification denotes an anti-asthmatic agent with the molecular formula C18H23N5O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W2KGP0434Y, chemically known as 1-(piperidinomethyl)-4-propyl-s-triazolo(4,3-a)quinazolin-5(4h)-one but generally known as binizolast, which bears US NIH Compound Identifier 185461. European Medicines Agency schedules Binizolast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05838MIG.

UNSPSC 51161532 Binizolast is a Commodity code under which state and local governments procure generic pharmaceuticals and over-the-counter products through cooperative purchasing agreements. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, recently issued a Request for Proposal to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities in Minnesota and Oregon. Vendors must supply products through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—and provide comprehensive product information including National Drug Codes, SKUs, UPCs, generic descriptions, strength, dosage form, trade names, and packaging configurations. All products must comply with current Good Manufacturing Practices and the Drug Supply Chain Security Act, maintain contractual relationships with at least two of the three authorized wholesalers, and carry commercial general liability insurance of at least $5,000,000 per occurrence. Pricing evaluation is weighted heavily toward price competitiveness (75 percent), with the remaining 25 percent distributed across fixed pricing commitment, administrative compliance, EDI capability, and willingness to accept a 3 percent administrative fee.

MMCAP's cooperative purchasing vehicle spans multiple states, with Minnesota and Oregon explicitly named as participants. The RFP issued January 20, 2026 carries a proposal due date of March 26, 2026, with a questions cutoff of February 18, 2026; awarded vendors will be notified by May 15, 2026 with contracts effective July 1, 2026. The initial contract term runs two years for new responders with optional extensions at MMCAP's discretion, while incumbents' amendments align with existing expiration dates through June 30, 2028. The solicitation does not disclose specific award values or budget ranges; however, vendors should anticipate a 3 percent administrative fee on all contract purchases and potential performance penalties ranging from $200 to $1,500 per violation for late reporting, missed onboarding, or improper denials.